Key result
LVA ablation plus PVI cuts AF/AT recurrence by ~34% versus PVI alone when LAD exceeds 44mm.
Why the study?
In the SUPPRESS-AF trial, LVA ablation efficacy depended on atrial remodeling, prompting evaluation of its efficacy across patient groups stratified by left atrial diameter.
Does pulmonary vein isolation followed by left atrial low-voltage-area ablation improve AF/AT recurrence-free rates in persistent AF patients with left atrial LVAs?
RCT (n=342)
Randomized
Does pulmonary vein isolation followed by left atrial low-voltage-area ablation improve AF/AT recurrence-free rates in persistent AF patients with left atrial LVAs?
Low-voltage-area ablation in addition to PVI significantly improves AF/AT recurrence-free rates in persistent AF patients with advanced left atrial enlargement (LAD > 44 mm).
Answers are grounded in this paper and cite their sources.
Targeting low-voltage areas may benefit persistent AF patients with severe atrial enlargement; extends prior trial.
Background A randomized controlled SUPPRESS-AF trial showed that the efficacy of low-voltage-area (LVA) ablation was highly dependent on the degree of atrial remodeling, while the efficacy was not statistically significant in total patients. Purpose The purpose of this subanalysis of SUPPRESS-AF trial was to compare the efficacy of LVA ablation in each patient group classified according to left atrial diameter (LAD) which is commonly used atrial remodeling index. Methods SUPPRESS-AF trial included persistent AF patients with left atrial LVAs and compared rhythm outcomes between patients randomized to undergo pulmonary vein isolation (PVI) followed by left atrial LVA ablation (LVA-ABL group, n=170) or PVI alone (PVI-alone group, n=172). In this post-hoc sub-analysis, the patients in the either of the two randomly allocated groups were further divided into 2 groups using a median LAD of 44 mm. Results There was no difference in AF/AT recurrence-free rates between patients with LAD > 44 mm and ≤ 44 mm (60.1% vs. 53.7%, p=0.261). Among patients with LAD > 44 mm, LVA-ABL group demonstrated higher AF/AT-recurrence-free rate than PVI-alone group (62.5% vs. 43.4%, p = 0.016, Figure 1). On the other hand, no difference in AF/AT recurrence-free rate was found between the 2 groups in patients with LAD ≤ 44 mm (60.8% vs. 59.6%, p=0.986). Hazard ratios of AF/AT recurrence in the LVA-ABL group to the PVI-alone group stratified by left atrial revealed that the efficacy of LVA ablation appears to become more pronounced with increasing LAD (Figure 2). Conclusions The efficacy of LVA ablation in addition to PVI for the treatment of persistent AF was more pronounced in patients with a large left atrium.
No takes yet. Share an insight, caveat, or question.
Masuda et al. (2025) conducted an RCT in Persistent atrial fibrillation with left atrial low-voltage areas (n=342). Pulmonary vein isolation (PVI) followed by left atrial LVA ablation vs. PVI alone was evaluated on AF/AT recurrence-free rate in patients with LAD > 44 mm (p=0.016). Low-voltage-area ablation in addition to PVI improved AF/AT-recurrence-free rates compared to PVI alone in persistent AF patients with a left atrial diameter > 44 mm.
Synapse has enriched 10 related papers. Consider them for comparative context: